Design principles for bifunctional targeted oligonucleotide enhancers of splicing.
Nucleic Acids Res. 2011 Sep 1; 39(16):7194-208
Owen N, Zhou H, Malygin AA, Sangha J, Smith LD, Muntoni F, Eperon IC. Nucleic Acids Res. 2011 Sep 1; 39(16):7194-208
The modification of splicing of pre-mRNA transcripts is a goal for gene therapy for diseases resulting from aberrant splicing. In the case of spinal muscular atrophy (SMA), the goal is to include exon 7, which is skipped in most transcripts from the SMN2 gene. This article presents a thorough analysis of the efficacy of bifunctional...
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.Subscribe for $9.95/month
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.Recommend to your Librarian
If you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.Request an Institutional Trial
your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.